Carlisle Companies Incorporated Stock News

And how could I not? After exploring Brighton Beach and Bristol, and then Cornwall all the way to St. Ives and Penzance, I wrapped up my Great Britain trip with a couple days in London.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Carlisle Companies Incorporated (NYSE: CSL) today announced that its Board of Directors approved a 14% increase in the Company's regular quarterly dividend from $1.10 to $1.25 per share, or to $5 per share on an annualized basis. The dividend is payable on September 1, 2026, to shareholders of record at the close of business on August 19, 2026. With this incr...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Carlisle Companies Incorporated (NYSE:CSL) today launched “Made with America,” a video celebrating America's 250th anniversary and Carlisle's own 109-year history as an American manufacturer contributing to the nation's storied growth and resilience. Since its founding in 1917, Carlisle has contributed to American innovation, strengthened infrastructure, crea...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Carlisle Companies Incorporated (NYSE:CSL) today announced the publication of its 2025 Corporate Sustainability Report, showcasing continued progress against its three-pillar sustainability strategy of manufacturing energy efficient products, reducing emissions, and diverting landfill waste. Rooted in more than a century of innovation and powered by the Carli...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Carlisle Companies Incorporated (NYSE:CSL) today announced its second quarter 2026 financial results. Record revenue of $1.6 billion, up 8% year-over-year Record diluted EPS of $6.36 and record adj. EPS of $7.03, up 12% year-over-year Operating margin of 22.4% and adj. EBITDA margin of 26.2% Repurchased $250 million of shares, increasing share repurchase targ...

Australian biotechnology firm CSL said on Wednesday it would start clinical trials ​to support regulatory approval for a new ‌manufacturing process aimed at lifting immunoglobulin output from the same amount of plasma.

Carlisle is contemplating its next move after Owens Corning appears unreceptive so far.